EPHB6 augments both development and drug sensitivity of triple-negative breast cancer tumours.
published in: Oncogene
date of publication: 2018-04-27
language: English
main subject: triple-negative breast cancer
Cites articles 65
- 2014-03-01
- 2013-09-01
Date
Title
Article - wd:Q52560135